Clinuvel Pharmaceuticals Limited (CUV.AX)
AUD 11.42
(-1.47%)
AUD 11.42
(-1.47%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 231.12 Million AUD | 18.81% |
| 2023 | 194.52 Million AUD | 34.33% |
| 2022 | 144.81 Million AUD | 33.39% |
| 2021 | 108.56 Million AUD | 33.14% |
| 2020 | 81.54 Million AUD | 30.79% |
| 2019 | 62.34 Million AUD | 45.31% |
| 2018 | 42.9 Million AUD | 49.98% |
| 2017 | 28.6 Million AUD | 42.05% |
| 2016 | 20.13 Million AUD | 47.6% |
| 2015 | 13.64 Million AUD | -20.46% |
| 2014 | 17.15 Million AUD | 8.47% |
| 2013 | 15.81 Million AUD | -1.13% |
| 2012 | 15.99 Million AUD | -20.68% |
| 2011 | 20.16 Million AUD | -31.66% |
| 2010 | 29.5 Million AUD | -29.09% |
| 2009 | 41.61 Million AUD | -24.3% |
| 2008 | 54.97 Million AUD | -18.95% |
| 2007 | 67.82 Million AUD | 297.31% |
| 2006 | 17.07 Million AUD | 69.76% |
| 2005 | 10.05 Million AUD | -1.87% |
| 2004 | 10.24 Million AUD | 27.04% |
| 2003 | 8.06 Million AUD | -23.33% |
| 2002 | 10.52 Million AUD | -23.59% |
| 2001 | 13.76 Million AUD | -10.83% |
| 2000 | 15.44 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 211.68 Million AUD | 0.0% |
| 2024 Q4 | 231.12 Million AUD | 0.0% |
| 2024 FY | 231.12 Million AUD | 18.81% |
| 2023 FY | 194.52 Million AUD | 34.33% |
| 2023 Q2 | 160.29 Million AUD | 0.0% |
| 2023 Q4 | 194.52 Million AUD | 0.0% |
| 2022 FY | 144.81 Million AUD | 33.39% |
| 2022 Q4 | 144.81 Million AUD | 0.0% |
| 2022 Q2 | 115.65 Million AUD | 0.0% |
| 2021 Q4 | 108.56 Million AUD | 0.0% |
| 2021 FY | 108.56 Million AUD | 33.14% |
| 2021 Q2 | 87.88 Million AUD | 0.0% |
| 2020 Q4 | 81.54 Million AUD | 0.0% |
| 2020 Q2 | 62.07 Million AUD | 0.0% |
| 2020 FY | 81.54 Million AUD | 30.79% |
| 2019 FY | 62.34 Million AUD | 45.31% |
| 2019 Q2 | 45.7 Million AUD | 0.0% |
| 2019 Q4 | 62.34 Million AUD | 0.0% |
| 2018 FY | 42.9 Million AUD | 49.98% |
| 2018 Q4 | 42.9 Million AUD | 0.0% |
| 2018 Q2 | 30.15 Million AUD | 0.0% |
| 2017 Q4 | 28.6 Million AUD | 0.0% |
| 2017 Q2 | 22.84 Million AUD | 0.0% |
| 2017 FY | 28.6 Million AUD | 42.05% |
| 2016 Q4 | 20.13 Million AUD | 0.0% |
| 2016 FY | 20.13 Million AUD | 47.6% |
| 2016 Q2 | 11.28 Million AUD | 0.0% |
| 2015 Q2 | 14.59 Million AUD | 0.0% |
| 2015 FY | 13.64 Million AUD | -20.46% |
| 2015 Q4 | 13.64 Million AUD | 0.0% |
| 2014 FY | 17.15 Million AUD | 8.47% |
| 2014 Q2 | 12.71 Million AUD | 0.0% |
| 2014 Q4 | 17.15 Million AUD | 0.0% |
| 2013 Q4 | 15.81 Million AUD | 0.0% |
| 2013 FY | 15.81 Million AUD | -1.13% |
| 2013 Q3 | 15.81 Million AUD | 23.83% |
| 2013 Q2 | 12.77 Million AUD | 0.0% |
| 2013 Q1 | 12.77 Million AUD | -20.15% |
| 2012 FY | 15.99 Million AUD | -20.68% |
| 2012 Q4 | 15.99 Million AUD | 0.0% |
| 2011 FY | 20.16 Million AUD | -31.66% |
| 2011 Q4 | 20.16 Million AUD | 0.0% |
| 2010 FY | 29.5 Million AUD | -29.09% |
| 2010 Q4 | 29.5 Million AUD | 0.0% |
| 2009 FY | 41.61 Million AUD | -24.3% |
| 2009 Q4 | 41.61 Million AUD | 0.0% |
| 2008 FY | 54.97 Million AUD | -18.95% |
| 2008 Q4 | 54.97 Million AUD | 0.0% |
| 2007 Q4 | 67.82 Million AUD | 0.0% |
| 2007 FY | 67.82 Million AUD | 297.31% |
| 2006 FY | 17.07 Million AUD | 69.76% |
| 2006 Q4 | 17.07 Million AUD | 0.0% |
| 2005 FY | 10.05 Million AUD | -1.87% |
| 2005 Q4 | 10.05 Million AUD | 0.0% |
| 2004 Q4 | 10.24 Million AUD | 0.0% |
| 2004 FY | 10.24 Million AUD | 27.04% |
| 2003 Q4 | 8.06 Million AUD | 0.0% |
| 2003 FY | 8.06 Million AUD | -23.33% |
| 2002 FY | 10.52 Million AUD | -23.59% |
| 2002 Q4 | 10.52 Million AUD | 0.0% |
| 2001 FY | 13.76 Million AUD | -10.83% |
| 2000 FY | 15.44 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | -4047.201% |
| Acrux Limited | 8.96 Million AUD | -2478.641% |
| Actinogen Medical Limited | 21.31 Million AUD | -984.483% |
| AnteoTech Limited | 9.38 Million AUD | -2363.694% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -1311.221% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -1639.775% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -13727.959% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -1102.282% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -1456.9% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -3057.723% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -7214.985% |
| Biome Australia Limited | 8.27 Million AUD | -2692.43% |
| Biotron Limited | 493.47 Thousand AUD | -46735.824% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | -105.508% |
| BTC Health Limited | 5.14 Million AUD | -4388.876% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -1413.267% |
| CSL Limited | 56.93 Billion AUD | 99.594% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | -49.47% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -2655.312% |
| Dimerix Limited | 32.07 Million AUD | -620.493% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | -804.523% |
| Hexima Limited | 2.26 Million AUD | -10086.123% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -8912.523% |
| Immuron Limited | 15.54 Million AUD | -1386.328% |
| Immutep Limited | 147.44 Million AUD | -56.748% |
| Imugene Limited | 151.39 Million AUD | -52.66% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -3676.497% |
| Memphasys Limited | 12.43 Million AUD | -1759.379% |
| Nanollose Limited | 241.95 Thousand AUD | -95424.941% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 6.794% |
| Noxopharm Limited | 6.78 Million AUD | -3307.013% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -4151.82% |
| Nyrada Inc. | 5.9 Million AUD | -3812.532% |
| Orthocell Limited | 26.61 Million AUD | -768.389% |
| PharmAust Limited | 11.12 Million AUD | -1977.543% |
| Patrys Limited | 4.16 Million AUD | -5453.745% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | -743.811% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -2025.252% |
| Prescient Therapeutics Limited | 20.39 Million AUD | -1033.356% |
| PYC Therapeutics Limited | 91.23 Million AUD | -153.317% |
| Race Oncology Limited | 20.22 Million AUD | -1042.56% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | -220.843% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -3528.533% |
| Starpharma Holdings Limited | 36.81 Million AUD | -527.814% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 41.973% |
| Tissue Repair Ltd | 19.38 Million AUD | -1091.999% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -4358.903% |